Search Results

You are looking at 1 - 1 of 1 items for

  • Author: C M Croce x
  • Refine by access: All content x
Clear All Modify Search
P Pallante
Search for other papers by P Pallante in
Google Scholar
PubMed
Close
,
R Visone
Search for other papers by R Visone in
Google Scholar
PubMed
Close
,
M Ferracin
Search for other papers by M Ferracin in
Google Scholar
PubMed
Close
,
A Ferraro
Search for other papers by A Ferraro in
Google Scholar
PubMed
Close
,
M T Berlingieri
Search for other papers by M T Berlingieri in
Google Scholar
PubMed
Close
,
G Troncone
Search for other papers by G Troncone in
Google Scholar
PubMed
Close
,
G Chiappetta
Search for other papers by G Chiappetta in
Google Scholar
PubMed
Close
,
C G Liu
Search for other papers by C G Liu in
Google Scholar
PubMed
Close
,
M Santoro
Search for other papers by M Santoro in
Google Scholar
PubMed
Close
,
M Negrini
Search for other papers by M Negrini in
Google Scholar
PubMed
Close
,
C M Croce
Search for other papers by C M Croce in
Google Scholar
PubMed
Close
, and
A Fusco
Search for other papers by A Fusco in
Google Scholar
PubMed
Close

MicroRNAs (miRNAs) are a class of small non-coding RNAs involved in a wide range of basic processes such as cell proliferation, development, apoptosis and stress response. It has recently been found that they are also abnormally expressed in many types of human cancer. We analyzed the genome-wide miRNA expression profile in human thyroid papillary carcinomas (PTCs) using a microarray (miRNACHIP microarray) containing hundreds of human precursor and mature miRNA oligonucleotide probes. Using this approach, we found an aberrant miRNA expression profile that clearly differentiates PTCs from normal thyroid tissues. In particular, a significant increase in miRNA (miR)-221, -222 and -181b was detected in PTCs in comparison with normal thyroid tissue. These results were further confirmed by northern blot and quantitative RT-PCR analyses. Moreover, RT-PCR revealed miR-221, -222 and -181b overexpression in fine needle aspiration biopsies corresponding to thyroid nodules, which were eventually diagnosed as papillary carcinomas after surgery. Finally, miR-221, -222 and -181b overexpression was also demonstrated in transformed rat thyroid cell lines and in mouse models of thyroid carcinogenesis. Functional studies, performed by blocking miR-221 function and by overexpressing miR-221 in human PTC-derived cell lines, suggest a critical role of miR-221 overexpression in thyroid carcinogenesis. In conclusion, these data, taken together, indicate an miRNA signature associated with PTCs, and suggest miRNA deregulation as an important event in thyroid cell transformation.

Free access